529 related articles for article (PubMed ID: 26753006)
1. Pharmacologic resistance in colorectal cancer: a review.
Hammond WA; Swaika A; Mody K
Ther Adv Med Oncol; 2016 Jan; 8(1):57-84. PubMed ID: 26753006
[TBL] [Abstract][Full Text] [Related]
2. Maintenance strategy in metastatic colorectal cancer: A systematic review.
Esin E; Yalcin S
Cancer Treat Rev; 2016 Jan; 42():82-90. PubMed ID: 26608114
[TBL] [Abstract][Full Text] [Related]
3. HER2-targeted therapy: an emerging strategy in advanced colorectal cancer.
La Salvia A; Lopez-Gomez V; Garcia-Carbonero R
Expert Opin Investig Drugs; 2019 Jan; 28(1):29-38. PubMed ID: 30513002
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
6. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
Nuhn P; De Bono JS; Fizazi K; Freedland SJ; Grilli M; Kantoff PW; Sonpavde G; Sternberg CN; Yegnasubramanian S; Antonarakis ES
Eur Urol; 2019 Jan; 75(1):88-99. PubMed ID: 29673712
[TBL] [Abstract][Full Text] [Related]
7. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
Jain VK; Hawkes EA; Cunningham D
Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer.
Duan L; Yang W; Feng W; Cao L; Wang X; Niu L; Li Y; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
Ther Adv Med Oncol; 2020; 12():1758835920947342. PubMed ID: 32922521
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Piawah S; Venook AP
Cancer; 2019 Dec; 125(23):4139-4147. PubMed ID: 31433498
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Colon Cancer: A Clinician's Perspective in 2019.
Ahmed M
Gastroenterology Res; 2020 Feb; 13(1):1-10. PubMed ID: 32095167
[TBL] [Abstract][Full Text] [Related]
12. Emerging Systemic Therapies for Colorectal Cancer.
Veenstra CM; Krauss JC
Clin Colon Rectal Surg; 2018 May; 31(3):179-191. PubMed ID: 29720904
[TBL] [Abstract][Full Text] [Related]
13. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer.
Lee SY; Oh SC
Biomed Res Int; 2016; 2016():7590245. PubMed ID: 27127793
[TBL] [Abstract][Full Text] [Related]
14. Cellular therapy: A promising tool in the future of colorectal surgery.
El-Said MM; Emile SH
World J Gastroenterol; 2019 Apr; 25(13):1560-1565. PubMed ID: 30983816
[TBL] [Abstract][Full Text] [Related]
15. Invitro Evaluation of Torin2 and 2, 6-Dihydroxyacetophenone in Colorectal Cancer Therapy.
Awasthi A; Kumar P; Srikanth CV; Sahi S; Puria R
Pathol Oncol Res; 2019 Jan; 25(1):301-309. PubMed ID: 29103204
[TBL] [Abstract][Full Text] [Related]
16. Developments in immunotherapy for gastrointestinal cancer.
Diaz JL; Wanta SM; Fishbein TM; Kroemer A
Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
[TBL] [Abstract][Full Text] [Related]
17. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
Berge E; Thompson C; Messersmith W
Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
